ECM
CELG

EagleClaw Capital Management’s Celgene Corp CELG Stock Holding History

EagleClaw Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-6,574
Closed -$655K – 135
2019
Q3 		$655K Sell
6,574
-6,100
-48% -$580K 0.27% 85
2019
Q2 		$1.17M Sell
12,674
-4,675
-27% -$444K 0.51% 63
2019
Q1 		$1.63M Hold
17,349
– – 0.75% 46
2018
Q4 		$1.11M Buy
17,349
+3,039
+21% +$224K 0.58% 56
2018
Q3 		$1.28M Buy
14,310
+700
+5% +$61.9K 0.56% 58
2018
Q2 		$1.09M Buy
13,610
+350
+3% +$29.1K 0.53% 63
2018
Q1 		$1.18M Buy
13,260
+1,350
+11% +$130K 0.6% 58
2017
Q4 		$1.24M Buy
11,910
+550
+5% +$62.1K 0.62% 56
2017
Q3 		$1.66M Sell
11,360
-25
-0.2% -$3.4K 0.94% 43
2017
Q2 		$1.48M Buy
11,385
+500
+5% +$61.3K 0.87% 48
2017
Q1 		$1.35M Buy
10,885
+150
+1% +$18K 0.81% 50
2016
Q4 		$1.24M Hold
10,735
– – 0.78% 49
2016
Q3 		$1.11M Buy
10,735
+550
+5% +$59.5K 0.71% 50
2016
Q2 		$1.01M Buy
10,185
+3,235
+47% +$335K 0.67% 52
2016
Q1 		$698K Buy
+6,950
New +$716K 0.47% 61

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

EagleClaw Capital Management's CELG Position: Q4 2019 in Review

EagleClaw Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 6,574 shares — an estimated $655K sold.

EagleClaw Capital Management first reported a position in CELG in Q1 2016 and held it in 15 quarters. The position peaked at $1.66M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • EagleClaw Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • EagleClaw Capital Management sold 6,574 Celgene Corp shares in Q4 2019, an estimated $655K.
  • EagleClaw Capital Management first reported a position in Celgene Corp in Q1 2016 and held it in 15 quarters.
  • EagleClaw Capital Management's Celgene Corp position peaked at $1.66M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on EagleClaw Capital Management's 13F filing for Q4 2019, filed 27 Jan 2020.